TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Annamaria BiczokTheo KrausBogdana SuchorskaNicole A TerpolilliJun ThorsteinsdottirArmin GieseJoerg C TonnChristian SchichorPublished in: Journal of neuro-oncology (2018)
Presence of TERT promoter mutation is associated with shorter progression free survival and overall survival in meningiomas WHO grade II and III. In these tumors, TERT promoter mutation should be considered as a clinically relevant prognostic factor to identify high risk patients.